CTI Biopharma reported 702K in Stock for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Baxter International BAX:US $ 2663M 115M
Bristol Myers Squibb BMY:US $ 2142M 38M
CTI Biopharma CTIC:US 702K 600K
Cytori Therapeutics CYTX:US $ 0M 0M
Eli Lilly And LLY:US $ 3899.4M 6.4M
Novartis NOVN:VX SF 6880M 117M
Seattle Genetics SGEN:US $ 319.35M 43.61M
YTE INCY:US $ 54.5M 19.05M